Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nabriva Therapeutics plc | Gen Counsel & Corp Secretary | Ordinary Shares | 41.2K | $61.8K | $1.50 | Aug 31, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NBRV | Nabriva Therapeutics plc | Aug 31, 2021 | 1 | -$39 | 4 | Sep 2, 2021 | Gen Counsel & Corp Secretary |
NBRV | Nabriva Therapeutics plc | Aug 6, 2021 | 1 | -$87 | 4 | Aug 10, 2021 | Gen Counsel & Corp Secretary |
NBRV | Nabriva Therapeutics plc | Jul 31, 2021 | 1 | -$41 | 4 | Aug 3, 2021 | Gen Counsel & Corp Secretary |
NBRV | Nabriva Therapeutics plc | Jul 6, 2021 | 1 | -$94 | 4 | Jul 8, 2021 | Gen Counsel & Corp Secretary |
NBRV | Nabriva Therapeutics plc | Jun 30, 2021 | 1 | -$50 | 4 | Jul 2, 2021 | Gen Counsel & Corp Secretary |
NBRV | Nabriva Therapeutics plc | Jun 6, 2021 | 1 | -$98 | 4 | Jun 8, 2021 | Gen Counsel & Corp Secretary |
NBRV | Nabriva Therapeutics plc | May 31, 2021 | 1 | -$51 | 4 | Jun 2, 2021 | Gen Counsel & Corp Secretary |
NBRV | Nabriva Therapeutics plc | May 6, 2021 | 1 | -$110 | 4 | May 10, 2021 | Gen Counsel & Corp Secretary |